These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 29440144)
1. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways. Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144 [TBL] [Abstract][Full Text] [Related]
2. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling. Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma. Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967 [TBL] [Abstract][Full Text] [Related]
5. Integrin Zhang YL; Xing X; Cai LB; Zhu L; Yang XM; Wang YH; Yang Q; Nie HZ; Zhang ZG; Li J; Zhang XL J Immunol Res; 2018; 2018():4602570. PubMed ID: 29951557 [TBL] [Abstract][Full Text] [Related]
6. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma. Wong KF; Liu AM; Hong W; Xu Z; Luk JM Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911 [TBL] [Abstract][Full Text] [Related]
7. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism. Tang JC; Liu JH; Liu XL; Liang X; Cai XJ World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967 [TBL] [Abstract][Full Text] [Related]
8. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway. Bao L; Yuan L; Li P; Bu Q; Guo A; Zhang H; Cui N; Liu B Cell Physiol Biochem; 2018; 50(2):437-451. PubMed ID: 30308519 [TBL] [Abstract][Full Text] [Related]
9. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
10. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling. Cheng Y; Hou T; Ping J; Chen T; Yin B J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064 [TBL] [Abstract][Full Text] [Related]
11. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway. Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724 [TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648 [TBL] [Abstract][Full Text] [Related]
13. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways. Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650 [TBL] [Abstract][Full Text] [Related]
14. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma. Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516 [TBL] [Abstract][Full Text] [Related]
15. Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D. Li S; Liu Y; Bai Y; Chen M; Cheng D; Wu M; Xia J Hepatology; 2021 Jun; 73(6):2361-2379. PubMed ID: 33205519 [TBL] [Abstract][Full Text] [Related]
16. Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma. Yang F; Wei Y; Han D; Li Y; Shi S; Jiao D; Wu J; Zhang Q; Shi C; Yang L; Song W; Zhang J; Han Y; Zhang R; Yang AG; Dimitrov DS; Zhao A; Qin W; Wen W Cancer Res; 2020 Sep; 80(18):3892-3905. PubMed ID: 32591411 [TBL] [Abstract][Full Text] [Related]
17. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442 [TBL] [Abstract][Full Text] [Related]
18. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity. Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168 [TBL] [Abstract][Full Text] [Related]
19. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
20. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma. Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]